Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD7 CAR-T cells

anti-CD7 chimeric antigen receptor T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD7 CAR-T cells, covering 2025-12-26 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Phase 1]

See pricing